40 minutes ago
1 hour ago
Fearon discusses results from the ALL-RISE trial, which demonstrated the FFRangio’s efficacy in assessing lesions for patients with coronary artery disease.
1 hour ago
Stay updated with the latest healthcare breakthroughs, including late breaking data from 3 conferences, in this week’s essential news roundup.
2 hours ago
Results of the MOMENTUM trial suggest the prevalence of hypercortisolism in resistant hypertension could be greater than previous estimates have indicated.
3 hours ago
Although not statistically significant, the reduction represents a potential new pathway for treating patients with STEMI.